CoChat

Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose

Open access

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 2 of the 15 sources its claims cite were checked for support.

Abstract

A novel lipid inhibition peptide Leu-Leu-Val-Val-Try-Pro-Trp-Thr-Gln-Arg (PP1) (MW 1274.53 Da) was obtained from Chlorella pyenoidose using enzymatic hydrolysis, gel filtration chromatography, and LC–MS/MS. Its lipid inhibition effects indicated that the synthetic peptide PP1 exhibits a good inhibitory effect against porcine pancreatic lipase (PL) (47.95%) at 200 μg/mL, which could be attributed to its hydrogen binding into catalytic sites of PL (Ser153, Asp177, and His 264) by docking analysis. Furthermore, in 3T3-L1 cells, the synthetic PP1 remarkedly decreased the accumulation of intracellular triacylglycerol (27.9%, 600 μg/mL), which carried a similar consequence as the positive drug simvastatin (24.1%, 10 μM). Western blot revealed that PP1 inhibited the lipid accumulation and fatty acid synthesis in 3T3-L1 adipocytes in two pathways, primarily: nonalcoholic fatty liver disease (NAFLD) pathway (C/EBPα, SREBP-1c, AMPKα) and AMPK signaling pathway (SREBP-1c, PPARγ, AMPKα). In short, these results support that PP1 can be used as a potential agent against obesity.

Overview

CoChat Summary

TL;DR

This paper isolates a decapeptide from *Chlorella pyrenoidosa* (PP1: LLVVYPWTQR) and shows it inhibits porcine pancreatic lipase in vitro and reduces lipid accumulation in 3T3-L1 adipocytes. The authors conclude PP1 may be a potential anti-obesity agent.

Key findings

  • From *C. pyrenoidosa*, the authors extracted about 72.4% of whole proteins and found the Alcalase hydrolysate had the strongest lipase inhibition among hydrolysates, with IC50 87.79 ± 5.12 μg/mL.
  • After ultrafiltration and Sephadex G-25 separation, the peptide LLVVYPWTQR (PP1) was selected; its synthetic form had 97.06% purity and a measured molecular weight of 1274.53 Da.
  • Synthetic PP1 inhibited porcine pancreatic lipase by 47.95% ± 2.3% at 200 μg/mL.
  • In 3T3-L1 cells, PP1 reduced intracellular triacylglycerol to 59.82 ± 6.78 nmol/mg protein at 600 μg/mL; the abstract also reports a 27.9% decrease, compared with 24.1% for simvastatin at 10 μM.
  • Western blot results indicated PP1 increased AMPKα and decreased C/EBPα, SREBP-1c, and PPARγ, with the discussion stating these effects map to the NAFLD pathway and AMPK signaling pathway.

Methods

  • Proteins from *C. pyrenoidosa* were enzymatically hydrolyzed with pepsin, papain, trypsin, and Alcalase, then fractionated by ultrafiltration, gel filtration chromatography (Sephadex G-25), and LC–MS/MS identification.
  • The shortlisted peptide PP1 was chemically synthesized and tested for pancreatic lipase inhibition, followed by molecular docking against PL structure 1ETH with Orlistat and simvastatin as controls.
  • Anti-lipid effects were assessed in 3T3-L1 adipocytes using MTT, Oil Red O staining, triglyceride measurement, and Western blot for adipogenesis-related proteins.

Limitations

  • The paper states that the in vivo effects of PL inhibitors/PP1 remain for future work and that the structure–activity relationship will need further study.
  • Evident from the text: the cellular anti-obesity results are based on 3T3-L1 cells only, so they do not directly establish effects in animals or humans.
  • Evident from the text: the authors report docking and in vitro assays, but no direct experimental validation of the predicted binding mechanism in the enzyme is described.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/molecules24193527

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 (a) The curve of pancreatic lipase inhibitory activity of extracted proteins and enzymatic hydrolysates by Copper soap method; (b) elution curve of Alcalase hydrolysis on G25 (<5K); (c) LC–MS chromatogram of the active fraction A2 from RP-HPLC; MS, MS/MS spectra, and y and b ions spectra of PP1.
Figure 1 (a) The curve of pancreatic lipase inhibitory activity of extracted proteins and enzymatic hydrolysates by Copper soap method; (b) elution curve of Alcalase hydrolysis on G25 (<5K); (c) LC–MS chromatogram of the active fraction A2 from RP-HPLC; MS, MS/MS spectra, and y and b ions spectra of PP1.CC BY · PubMed Central
Figure 2 (a) Inhibition of lipase by the synthesized peptide by Copper soap method. (b) Docking analysis of the porcine pancreatic lipase (PDB code: 1ETH) with the decapeptide, showing hydrogen bond (blue sagittate), Van der Waals (green), and Electrostatic (pink). Two-dimensional diagrams of predicted interactions between the decapeptide and the porcine pancreatic lipase (PDB code: 1ETH), (A) PP1 (B) simvastatin, and (C) Orlistat. (c) Catalytic mechanism of lipase with lipid and polypeptide.
Figure 2 (a) Inhibition of lipase by the synthesized peptide by Copper soap method. (b) Docking analysis of the porcine pancreatic lipase (PDB code: 1ETH) with the decapeptide, showing hydrogen bond (blue sagittate), Van der Waals (green), and Electrostatic (pink). Two-dimensional diagrams of predicted interactions between the decapeptide and the porcine pancreatic lipase (PDB code: 1ETH), (A) PP1 (B) simvastatin, and (C) Orlistat. (c) Catalytic mechanism of lipase with lipid and polypeptide.CC BY · PubMed Central
Figure 3 (a) The effect of PP1 on 3T3-L1 cell viability. (b) Lipid accumulation was determined by Oil Red O. (c) PP1 inhibited intracellular lipid accumulation in 3T3-L1 adipocytes, 10 μM simvastatin was used as a positive group. (d) The protein expressions by Western blot. (e) The core network mapped by STRING analysis, CEBPA–C/EBPα, SREBF1–SREBP-1c, PPARG–PPARγ, PRKAA1–AMPKα.
Figure 3 (a) The effect of PP1 on 3T3-L1 cell viability. (b) Lipid accumulation was determined by Oil Red O. (c) PP1 inhibited intracellular lipid accumulation in 3T3-L1 adipocytes, 10 μM simvastatin was used as a positive group. (d) The protein expressions by Western blot. (e) The core network mapped by STRING analysis, CEBPA–C/EBPα, SREBF1–SREBP-1c, PPARG–PPARγ, PRKAA1–AMPKα.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 1 Not valid · 8 Not checked · 26 Own results and interpretations

15 more claims

Create a free account to see all 37 claims and to verify the 13 references still open.

See all claims — free account
  • Probably not a substantial claim. 6
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • It may state two separate claims as one. 12
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 34

Metadata

Authors
Zhang, R., Chen, J., Mao, X., Qi, P., & Zhang, X.
Affiliations
  • South China University of Technology (CN)
  • Guangzhou Institute for Food Inspection, Guangzhou 510640, China
Corresponding author
  • Mao, Xinwu
  • Zhang, Xuewu
Venue
Molecules
Publisher
MDPI AG
Published
2019-09-29
Volume
24
Issue
19
Pages
3527
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2976832584
Cited by
34
References
22
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 3 · 2021: 2 · 2020: 3
FWCI
1.78
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
Keywords
decapeptide, Chlorella pyrenoidosa, triglyceride accumulation, 3T3-L1 adipocytes, non-alcoholic fatty liver disease, AMPK signaling, SREBP-1c, PPARγ, C/EBPα, fatty acid synthesis, obesity, peptide synthesis, molecular docking
MeSH terms
Amino Acid Sequence, Animals, Chlorella, Dose-Response Relationship, Drug, Chemical Fractionation, Hydrolysis, Models, Molecular, Molecular Weight, Oligopeptides, Plant Extracts, Protein Conformation, Swine, Pancrelipase, 3T3-L1 Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.